SE8101421L - Inre salter av sulfooxi-triazinium, pyrimidinium och pyridinium hydroxid - Google Patents

Inre salter av sulfooxi-triazinium, pyrimidinium och pyridinium hydroxid

Info

Publication number
SE8101421L
SE8101421L SE8101421A SE8101421A SE8101421L SE 8101421 L SE8101421 L SE 8101421L SE 8101421 A SE8101421 A SE 8101421A SE 8101421 A SE8101421 A SE 8101421A SE 8101421 L SE8101421 L SE 8101421L
Authority
SE
Sweden
Prior art keywords
triazinium
pyrimidinium
sulfooxi
pyridinium
internal salts
Prior art date
Application number
SE8101421A
Other languages
English (en)
Other versions
SE448876B (sv
Inventor
J M Mccall
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of SE8101421L publication Critical patent/SE8101421L/sv
Publication of SE448876B publication Critical patent/SE448876B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/50Three nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/54Three nitrogen atoms
    • C07D251/70Other substituted melamines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
SE8101421A 1980-03-10 1981-03-05 Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa SE448876B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/128,995 US4287338A (en) 1980-03-10 1980-03-10 Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts

Publications (2)

Publication Number Publication Date
SE8101421L true SE8101421L (sv) 1981-09-11
SE448876B SE448876B (sv) 1987-03-23

Family

ID=22437996

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8101421A SE448876B (sv) 1980-03-10 1981-03-05 Inre salter av sulfoxi-triazinium-, -pyrimidinium- och -pyridiniumhydroxid och sett att framstella dessa

Country Status (15)

Country Link
US (1) US4287338A (sv)
JP (1) JPS56150066A (sv)
AU (1) AU536166B2 (sv)
BE (1) BE887850A (sv)
CA (1) CA1154761A (sv)
CH (1) CH645626A5 (sv)
DE (1) DE3107583A1 (sv)
FI (1) FI70410C (sv)
FR (1) FR2477541A1 (sv)
GB (1) GB2071092B (sv)
HK (1) HK98088A (sv)
IT (1) IT1142667B (sv)
NL (1) NL8101114A (sv)
SE (1) SE448876B (sv)
ZA (1) ZA811057B (sv)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US5183817A (en) * 1981-02-17 1993-02-02 Bazzano Gail S Combinations of retinoids and minoxidil-type compounds for hair growth
US4532240A (en) * 1982-09-09 1985-07-30 Warner-Lambert Company Diaminopyrimidines
DE3670765D1 (en) * 1985-01-25 1990-06-07 Upjohn Co Pyrimidinsulfate fuer haarwuchs.
FR2590897B1 (fr) * 1985-12-06 1988-02-19 Kemyos Bio Medical Research Sr Nouveaux derives de 6 amino 1,2-dihydro-1-hydroxy-2-imino-pyrimidine, leur procede de preparation et compositions cosmetiques les renfermant
US4927626A (en) * 1988-10-28 1990-05-22 Devillez Richard L Method for enhancement of unguis growth
FR2651122B1 (fr) * 1989-08-29 1994-10-28 Oreal Compositions destinees a etre utilisees pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives de l'amino-2 pyrimidine oxyde-3 et nouveaux composes derives de l'amino-2 pyrimidine oxyde-3.
GB8929022D0 (en) * 1989-12-22 1990-02-28 Ici Plc Diazine derivatives
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
AU651630B2 (en) * 1990-11-14 1994-07-28 Pharmacia & Upjohn Company 5-fluoro-2,4,6-pyrimidinetriamine compounds
FR2671082B1 (fr) * 1990-12-28 1993-04-16 Oreal Agent a plusieurs composants ou kit de preparation de la forme sulfo-conjuguee de composes pyrimidino- ou triazino-n-oxyde et procede de mise en óoeuvre.
FR2677884B1 (fr) * 1991-06-20 1993-07-09 Oreal Composition pour freiner la chute des cheveux a base de pyrimidines n-oxyde trisubstitues ou leurs derives sulfoconjugues, nouveaux composes pyrimidines n-oxyde ou leurs derives sulfoconjugues.
ATE289993T1 (de) 1997-08-01 2005-03-15 Reilly Ind Inc Supernukleophile in 4-stellung substituierte pyridinkatalysatoren und verfahren die nützlich zu deren herstellung sind
US7705010B2 (en) * 2005-02-22 2010-04-27 Cedars-Sinai Medical Center Use of minoxidil sulfate as an anti-tumor drug
CL2008000467A1 (es) * 2007-02-14 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
EP2144877A1 (en) * 2007-04-04 2010-01-20 UCB Pharma, S.A. Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3382248A (en) * 1965-11-01 1968-05-07 Upjohn Co 6-amino-4, 5-di(substituted amino)-1, 2-dihydro-1-hydroxy-2-iminopyrimidines
US3464987A (en) * 1966-02-21 1969-09-02 Upjohn Co 1,2-dihydro-1-hydroxy-2-imino-6-(lower alkyl)pyrimidines
US3973016A (en) * 1974-08-05 1976-08-03 Warner-Lambert Company Blood pressure reducing hydroxypyrimidines
US4021562A (en) * 1975-12-08 1977-05-03 Mead Johnson & Company 4-Tertiary-amino-2,6-diaminopyridine 1-oxides

Also Published As

Publication number Publication date
CA1154761A (en) 1983-10-04
HK98088A (en) 1988-12-09
FI70410B (fi) 1986-03-27
IT8147976A0 (it) 1981-03-09
AU536166B2 (en) 1984-04-19
DE3107583C2 (sv) 1989-11-02
ZA811057B (en) 1982-03-31
JPH0145467B2 (sv) 1989-10-03
GB2071092B (en) 1983-09-07
FR2477541B1 (sv) 1984-06-01
US4287338A (en) 1981-09-01
DE3107583A1 (de) 1982-01-07
AU6737181A (en) 1981-09-17
IT1142667B (it) 1986-10-15
FI70410C (fi) 1986-09-19
JPS56150066A (en) 1981-11-20
SE448876B (sv) 1987-03-23
GB2071092A (en) 1981-09-16
NL8101114A (nl) 1981-10-01
CH645626A5 (de) 1984-10-15
FR2477541A1 (fr) 1981-09-11
FI810681L (fi) 1981-09-11
BE887850A (fr) 1981-09-09

Similar Documents

Publication Publication Date Title
SE8101421L (sv) Inre salter av sulfooxi-triazinium, pyrimidinium och pyridinium hydroxid
MY8700709A (en) 3-aryloxy-3-phenylprophylamines
LV12313A (lv) Leikotrienu antagonistu pielietojums
GB1309182A (en) Pyrimidine derivatives
BR8707571A (pt) Piridinassulfonilureias herbicidas
DE3382721D1 (de) Halopyridone.
ES8500894A1 (es) Procedimiento para preparar sales de acido 5,5'-azobis-salicico.
ES8604922A1 (es) Procedimiento para la preparacion de n-piridilindoles
NO159851C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive svovelsubstituerte fenoxypyridiner.
FI832519A0 (fi) Farmaceutiska foerfaranden och sammansaettningar
ATE6588T1 (de) Augenwasserpraeparat auf basis von chondroitinsulfat a.
GR76107B (sv)
SE7602840L (sv) Forfarande for framstellning av nikotinsyraamid
IE32475L (en) O-isopropylaminobenzophenones
DK262685D0 (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
ES523555A0 (es) Procedimiento para la obtencion de benzoil-(tio)ureas sustituidas.
SE8200515L (sv) Bicykliska foreningar
FR2514006B1 (sv)
SE8303435D0 (sv) New pyrazolopyridine derivative
FI832520A0 (fi) Farmaceutiska foerfaranden och sammansaettningar
ATE113938T1 (de) Heterocyclisch substituierte sulfonylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als herbizide oder pflanzenwachstumsregulatoren.
ATE1279T1 (de) Verfahren zur herstellung von trifluoracetylchlorid.
ES498994A0 (es) Procedimiento para la obtencion de (tio)hidantoinas
FR2443462A1 (fr) Procede de preparation de quinazolines substituees, quinazolines ainsi obtenues et methode de traitement de l'hypertension les utilisant
GB1180210A (en) New Bis-Alkanolamine Derivatives and process for their Production

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8101421-9

Effective date: 19941010

Format of ref document f/p: F